Centaurus Financial’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $804K | Sell |
2,067
-313
| -13% | -$122K | 0.05% | 344 |
|
|
2025
Q1 | $1.04M | Buy |
2,380
+131
| +6% | +$57K | 0.06% | 273 |
|
|
2024
Q4 | $830K | Buy |
2,249
+772
| +52% | +$285K | 0.05% | 304 |
|
|
2024
Q3 | $768K | Buy |
1,477
+559
| +61% | +$291K | 0.05% | 321 |
|
|
2024
Q2 | $498K | Buy |
918
+368
| +67% | +$200K | 0.03% | 390 |
|
|
2024
Q1 | $285K | Buy |
550
+259
| +89% | +$134K | 0.02% | 515 |
|
|
2023
Q4 | $137K | Buy |
+291
| New | +$137K | 0.01% | 683 |
|
|
2023
Q2 | – | Sell |
-760
| Closed | -$349K | – | 800 |
|
|
2023
Q1 | $349K | Buy |
+760
| New | +$349K | 0.03% | 501 |
|
|
2022
Q4 | – | Sell |
-661
| Closed | -$300K | – | 856 |
|
|
2022
Q3 | $300K | Buy |
+661
| New | +$300K | 0.03% | 486 |
|
|
2020
Q1 | – | Sell |
-2,065
| Closed | -$624K | – | 549 |
|
|
2019
Q4 | $624K | Buy |
+2,065
| New | +$624K | 0.09% | 260 |
|
|
2018
Q3 | – | Sell |
-597
| Closed | -$142K | – | 939 |
|
|
2018
Q2 | $142K | Buy |
+597
| New | +$142K | 0.02% | 602 |
|